BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 16538929)

  • 1. Morbidity and mortality in patients on dialysis: the impact of hemoglobin levels.
    Brattich M
    Nephrol Nurs J; 2006; 33(1):64-7, 90; quiz 68-9. PubMed ID: 16538929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between hemoglobin and hematocrit levels and hospitalization and survival rates in dialysis patients.
    Brattich M
    Nephrol Nurs J; 2003 Apr; 30(2):231-4. PubMed ID: 12737001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of mortality and hospitalization with achievement of adult hemoglobin targets in adolescents maintained on hemodialysis.
    Amaral S; Hwang W; Fivush B; Neu A; Frankenfield D; Furth S
    J Am Soc Nephrol; 2006 Oct; 17(10):2878-85. PubMed ID: 16943308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in hemoglobin level distribution in US dialysis patients from June 2006 to November 2008.
    Spiegel DM; Khan I; Krishnan M; Mayne TJ
    Am J Kidney Dis; 2010 Jan; 55(1):113-20. PubMed ID: 19932539
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study.
    Portolés J; López-Gómez JM; Aljama P
    Nephrol Dial Transplant; 2007 Feb; 22(2):500-7. PubMed ID: 17023492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study.
    Go AS; Yang J; Ackerson LM; Lepper K; Robbins S; Massie BM; Shlipak MG
    Circulation; 2006 Jun; 113(23):2713-23. PubMed ID: 16754803
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing the anemia of end-stage renal disease after hospitalization.
    Krishnan M; Adams E
    Nephrol Nurs J; 2004; 31(5):541-4. PubMed ID: 15518256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia management protocols: providing consistent hemoglobin outcomes.
    Michael M
    Nephrol Nurs J; 2005; 32(4):423-6. PubMed ID: 16180783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlates affecting survival in chronic hemodialysis patients: the combined impact of albumin and high hemoglobin levels on improving outcomes, local and national results.
    Capelli JP; Kushner H
    Hemodial Int; 2008 Oct; 12(4):450-62. PubMed ID: 19090868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The optimal hemoglobin in dialysis patients- a critical review.
    Singh AK; Fishbane S
    Semin Dial; 2008; 21(1):1-6. PubMed ID: 18251947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The "right" of passage: surviving the first year of dialysis.
    Wingard RL; Chan KE; Lazarus JM; Hakim RM
    Clin J Am Soc Nephrol; 2009 Dec; 4 Suppl 1():S114-20. PubMed ID: 19995993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocol adherence and the ability to achieve target haemoglobin levels in haemodialysis patients.
    Chan K; Moran J; Hlatky M; Lafayette R
    Nephrol Dial Transplant; 2009 Jun; 24(6):1956-62. PubMed ID: 19176685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL.
    Bradbury BD; Do TP; Winkelmayer WC; Critchlow CW; Brookhart MA
    Pharmacoepidemiol Drug Saf; 2009 Oct; 18(10):932-40. PubMed ID: 19572312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemoglobin levels, cardiovascular disease, and left ventricular hypertrophy in patients with chronic kidney disease. Case study of the anemic patient.
    Butler KG
    Nephrol Nurs J; 2002 Apr; 29(2):189-92. PubMed ID: 11997954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anemia as independent predictor of major events in elderly patients with chronic angina.
    Muzzarelli S; Pfisterer M;
    Am Heart J; 2006 Nov; 152(5):991-6. PubMed ID: 17070178
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is needed to achieve a hemoglobin of 11.0-13.0 g/dl in end-stage renal disease.
    Fishbane S
    Blood Purif; 2007; 25(1):53-7. PubMed ID: 17170538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of higher hemoglobin levels on mortality and hospitalization in hemodialysis patients.
    Ofsthun N; Labrecque J; Lacson E; Keen M; Lazarus JM
    Kidney Int; 2003 May; 63(5):1908-14. PubMed ID: 12675871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anaemia management in non-dialysis chronic kidney disease: flexibility of target to target stability?
    De Nicola L; Minutolo R; Conte G
    Nephron Clin Pract; 2010; 114(4):c236-41. PubMed ID: 20090364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anaemia and mortality in haemodialysis patients: interaction of propensity score for predicted anaemia and actual haemoglobin levels.
    Roberts TL; Foley RN; Weinhandl ED; Gilbertson DT; Collins AJ
    Nephrol Dial Transplant; 2006 Jun; 21(6):1652-62. PubMed ID: 16449283
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal anemia: comparing current Eastern and Western European management practice (ORAMA).
    Wiecek A; Covic A; Locatelli F; Macdougall IC;
    Ren Fail; 2008; 30(3):267-76. PubMed ID: 18350446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.